Temporal gene signature of myofibroblast transformation in Peyronie's disease: first insights into the molecular mechanisms of irreversibility
Ilg, Marcus M, Harding, Sophie, Lapthorn, Alice R, Kirvell, Sara, Ralph, David J, Bustin, Stephen A, Ball, Graham, Cellek, Selim
Published in Journal of sexual medicine (28.03.2024)
Published in Journal of sexual medicine (28.03.2024)
Get full text
Journal Article
Defining a temporal gene expression profile of myofibroblast transformation in peyronie's disease
Ilg, Marcus, Harding, Sophie, Lapthorn, Dr. Alice, Kirvell, Dr. Sara, Schurman, Nathan, Church, Sarah, Ralph, Prof. David, Bustin, Prof. Stephen, Cellek, Prof. Selim
Published in Journal of sexual medicine (01.11.2022)
Published in Journal of sexual medicine (01.11.2022)
Get full text
Journal Article
P06 A novel drug combination produces a synergistic effect when inhibiting myofibroblast transformation in an in vitro model of hypertrophic scarring
Lapthorn, Alice, Ilg, Marcus, Dziewulski, Peter, Cellek, Selim
Published in British journal of dermatology (1951) (17.05.2024)
Published in British journal of dermatology (1951) (17.05.2024)
Get full text
Journal Article
Phenotypic screening identifies hydroxypyridone anti-fungals as novel medicines for the prevention of hypertrophic scars
Lapthorn, Alice Ruth, Ilg, Marcus Maximillian, Sullivan, Justine Victoria, Dziewulski, Peter, Cellek, Selim
Published in European journal of pharmacology (15.12.2022)
Published in European journal of pharmacology (15.12.2022)
Get full text
Journal Article
(118) THE MECHANISM OF ACTION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS IN PREVENTING MYOFIBROBLAST TRANSFORMATION IN IN VITRO MODELS OF PEYRONIE’S DISEASE
Sophie L, Harding, Dr. Marcus M, Ilg, Dr. Alice R, Lapthorn, Prof. Selim, Cellek, Prof. David J, Ralph
Published in Journal of sexual medicine (06.07.2023)
Published in Journal of sexual medicine (06.07.2023)
Get full text
Journal Article